Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression

Journal of Infectious Diseases

Volumn 192, Issue 9, 2005, Pages 1597-1605

  Daar, Eric S ^a,g   Lynn, Henry S ^f   Donfield, Sharyne M ^c   Lail, Alice ^c   O'Brien, Stephen J ^d   Huang, Wei ^b   Winkler, Cheryl A ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONOGRAM BIOSCIENCES   (United States)

^c RHO INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e SAIC FREDERICK INC   (United States)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1; VIRUS RECEPTOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ALLELES; CD4 LYMPHOCYTE COUNT; CHEMOKINES, CXC; CHILD; COHORT STUDIES; DISEASE PROGRESSION; GENOTYPE; HEMOPHILIA A; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CXCR4; VIRAL LOAD;

EID: 27144436855     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/496893     Document Type: Article

References (40)

1. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992; 66:1354-60.
2. Berger EA, Doms RW, Fenyo EM, et al. A new classification for HIV-1. Nature 1998; 391:240.
3. Daar ES, Chernyavskiy T, Zhao JQ, Krogstad P, Chen ISY, Zack JA. Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1995; 11:3-9.
4. Connor RI, Mohri H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993; 67:1772-7.
5. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994; 169:968-74.
6. Koot M, Keet IPM, Vos AHV, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118:681-8.
7. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185:621-8.
8. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet 2004; 36:565-74.
9. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273:1856-62.
10. Martin MP, Dean M, Smith MW, et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282:1907-11.
11. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998; 351:1632-3.
12. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 277:959-65.
13. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86:367-77.
14. van Rij RP, de Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 1998; 178:1806-11.
15. Tiensiwakul P. Stromal cell-derived factor (SDF) 1-3′ A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais. Intervirology 2004; 47:87-92.
16. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998; 279: 389-93.
17. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 1998; 12:F85-90.
18. + T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis 2000; 182:311-5.
19. Mummidi S, Ahuja SS, Gonzalez E, et al. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998; 4:786-93.
20. Singh KK, Barroga CR, Hughes MD, et al. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis 2003; 188:1461-72.
21. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′ A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001; 135:782-95.
22. Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, Rowland-Jones SL. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis 1999; 180:1096-105.
23. Meyer L, Magierowska M, Hubert JB, et al. CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS. AIDS 1999; 13:624-6.
24. Soriano A, Martinez C1 Garcia F, et al. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3′ A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002; 186:922-31.
25. Hilgartner MW, Donfield SM, Willoughby A, et al. Hemophilia Growth and Development Study: design, methods and entry data. Am J Pediatr Hematol Oncol 1993; 15:208-18.
26. Daar ES, Lynn H, Donfield S, et al. Effects of plasma HIV RNA, CD4+ T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. J Acquir Immune Defic Syndr 1999; 21:317-25.
27. Centers for Disease Control and Prevention. Hemophilia surveillance system report. MMWR 1998; 1:1-14.
28. Dewar RL, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994; 170: 1172-9.
29. Petropoulos CJ, Parkin NT, Limoli KL, et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother 2000; 44:920-8.
30. Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003; 100:4144-9.
31. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immune deficiency. MMWR 1987; 36:1S-15S.
32. Longford N. Random coefficient models. Oxford: Clarendon Press, 1993.
33. Mazzucchelli R, Corvasce S, Violin M, et al. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals. J Biol Regul Homeost Agents 2001; 15:265-71.
34. Llano A, Barretina J, Blanco J, Gutierrez A, Clotet B, Este JA. Stromal-cell-derived factor 1 prevents the emergence of thesyncytium-inducing phenotype of HIV-1 in vivo. AIDS 2001; 15:1890-2.
35. Balotta C, Bagnarelli P, Corvasce S, et al. Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 1999; 180:285-9.
36. Watanabe MA, de Oliveira Cavassin GG, Orellana MD, et al. SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 2003; 35:31-4.
37. Tresoldi E, Romiti ML, Boniotto M, et al. Prognostic value of the stromal cell-derived factor 1 3′ A mutation in pediatric human immunodeficiency virus type 1 infection. J Infect Dis 2002; 185:696-700.
38. Lathey JL, Tierney C, Chang SY, et al. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy. J Infect Dis 2001; 184:1402-11.
39. Marechal V, Arenzana-Seisdedos F, Heard JM, Schwartz O. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication. J Virol 1999; 73:3608-15.
40. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:1434-40.